Microbiome modulators in the treatment of infectious diseases: insights from clinical trials
Authors:
Open Access
- 18 November 2024
- journal article
- letter
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 22 (1) , 1-3
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (82174178)
- Basic Public Welfare Research Programme of Zhejiang Province (LGD21H290001)
This publication has 5 references indexed in Scilit:
- Targeting the microbiome to improve human health with the approach of personalized medicine: Latest aspects and current updatesClinical Nutrition ESPEN, 2024
- Current Status of Probiotics as Supplements in the Prevention and Treatment of Infectious DiseasesFrontiers in Cellular and Infection Microbiology, 2022
- Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19?Nutrition Research Reviews, 2021
- Update of treatment algorithms for Clostridium difficile infectionClinical Microbiology and Infection, 2018
- The microbiome and critical illnessThe Lancet Respiratory Medicine, 2016